Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPensionProperty, Plant & Equipment (Net)Retained EarningsShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abivax (ABVX) Non-Current Assets (2022 - 2025)

Historic Non-Current Assets for Abivax (ABVX) over the last 4 years, with Q3 2025 value amounting to $38.3 million.

  • Abivax's Non-Current Assets changed N/A to $38.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $38.3 million, marking a year-over-year change of. This contributed to the annual value of $36.9 million for FY2024, which is 1691.71% down from last year.
  • Per Abivax's latest filing, its Non-Current Assets stood at $38.3 million for Q3 2025.
  • Over the past 5 years, Abivax's Non-Current Assets peaked at $44.7 million during Q2 2024, and registered a low of $36.1 million during Q1 2025.
  • For the 4-year period, Abivax's Non-Current Assets averaged around $39.8 million, with its median value being $38.3 million (2025).
  • Its Non-Current Assets has fluctuated over the past 5 years, first soared by 1008.56% in 2023, then tumbled by 1647.09% in 2024.
  • Abivax's Non-Current Assets (Quarter) stood at $40.2 million in 2022, then increased by 10.09% to $44.2 million in 2023, then dropped by 16.47% to $36.9 million in 2024, then grew by 3.7% to $38.3 million in 2025.
  • Its Non-Current Assets was $38.3 million in Q3 2025, compared to $38.0 million in Q2 2025 and $36.1 million in Q1 2025.